Market Closed - Euronext Paris 11:35:23 2024-04-15 am EDT After market 03:49:21 pm
105.2 EUR +0.57% Intraday chart for bioMérieux 104 -1.14%
Sales 2024 * 3.9B 4.15B Sales 2025 * 4.19B 4.46B Capitalization 12.36B 13.17B
Net income 2024 * 458M 488M Net income 2025 * 526M 560M EV / Sales 2024 * 3.08 x
Net cash position 2024 * 348M 371M Net cash position 2025 * 590M 629M EV / Sales 2025 * 2.81 x
P/E ratio 2024 *
26.9 x
P/E ratio 2025 *
24 x
Employees 13,696
Yield 2024 *
0.81%
Yield 2025 *
0.89%
Free-Float 35.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.96%
1 week+7.98%
Current month+3.28%
1 month+8.11%
3 months+6.47%
6 months+16.12%
Current year+4.97%
More quotes
1 week
100.70
Extreme 100.7
108.90
1 month
94.60
Extreme 94.6
108.90
Current year
94.26
Extreme 94.26
108.90
1 year
84.54
Extreme 84.54
108.90
3 years
77.48
Extreme 77.48
133.20
5 years
66.30
Extreme 66.3
144.80
10 years
25.44
Extreme 25.44
144.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 16-10-31
Chairman 50 04-04-15
Director of Finance/CFO 47 18-02-28
Members of the board TitleAgeSince
Director/Board Member 74 06-09-14
Director/Board Member 63 04-12-31
Chairman 50 04-04-15
More insiders
Date Price Change Volume
24-04-15 105.2 +0.57% 79 183
24-04-12 104.6 -0.10% 146,662
24-04-11 104.7 +0.48% 74,391
24-04-10 104.2 -1.88% 135,161
24-04-09 106.2 +8.59% 218,144

Real-time Euronext Paris, April 15, 2024 at 08:44 am EDT

More quotes
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
104.6 EUR
Average target price
112 EUR
Spread / Average Target
+7.03%
Consensus